Clinical Trial Update: Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tacrolimus and methotrexate with or without sirolimus to prevent graft-versus-host disease in young patients undergoing donor stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Graft-versus-host Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Children's Oncology Group | Conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission | Phase 3 | Status: COMPLETED | Results posted: 2017-02-09